CO-1.01
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CO-1.01, covering 2014-04-17 to 2019-03-11. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma [Phase 2]